ATI LPN
Pharmacology and the Nursing Process 10th Edition Test Bank
Chapter 32 : Diabetes Drugs Questions
Question 1 of 5
A patient is taking a sulfonylurea medication for new-onset type 2 diabetes mellitus. When reviewing potential adverse effects during patient teaching, the nurse will include information about which of these effects? (Select all that apply.)
Correct Answer: A,B,D
Rationale: Sulfonylureas can cause hypoglycemia due to increased insulin secretion, nausea as a GI side effect, and weight gain from insulin stimulation. Diarrhea and edema are not common.
Question 2 of 5
A patient will be taking U-500 insulin. The nurse is reviewing the use of this drug. Which of these statements are true? (Select all that apply.)
Correct Answer: A,B,D
Rationale: U-500 insulin is five times more concentrated than U-100, requires specific U-500 syringes, and each line measures 5 units. It delivers larger doses in smaller volumes, not smaller doses.
Question 3 of 5
The nurse is administering insulin lispro and will keep in mind that this insulin will start to have an effect within which time frame?
Correct Answer: A
Rationale: Insulin lispro, a rapid-acting insulin, has an onset of action within 15 minutes, making it effective shortly after administration. The other time frames refer to peak, half-life, or duration.
Question 4 of 5
When teaching about hypoglycemia, the nurse will make sure that the patient is aware of the early signs of hypoglycemia, including which of these?
Correct Answer: C
Rationale: Early hypoglycemia signs include confusion and sweating due to central nervous system and sympathetic activation. Hypothermia and seizures are later symptoms, nausea/diarrhea are unrelated, and fruity breath indicates ketoacidosis.
Question 5 of 5
The nurse is teaching a group of patients about self-administration of insulin. What content is important to include?
Correct Answer: D
Rationale: When mixing insulins, clear (regular) insulin is drawn up first to prevent contamination with cloudy (NPH) insulin. Rotation of injection sites is necessary, and compatible insulins can be mixed in one syringe.